160 related articles for article (PubMed ID: 2480413)
1. Role of serum alpha-fetoprotein in pre- and post-orthotopic liver transplantation (OLT) for malignant disease.
Andorno E; Salizzoni M; Schieroni R; De Hemptinne B
J Nucl Med Allied Sci; 1989; 33(3 Suppl):132-4. PubMed ID: 2480413
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
4. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Wang YL; Li G; Wu D; Liu YW; Yao Z
Transplant Proc; 2007; 39(1):166-8. PubMed ID: 17275497
[TBL] [Abstract][Full Text] [Related]
5. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer.
Mailey B; Artinyan A; Khalili J; Denitz J; Sanchez-Luege N; Sun CL; Bhatia S; Nissen N; Colquhoun SD; Kim J
Arch Surg; 2011 Jan; 146(1):26-33. PubMed ID: 21242442
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
11. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
[TBL] [Abstract][Full Text] [Related]
12. Pediatric liver transplantation for hepatoblastoma: a single center experience.
Kim T; Kim DY; Kim KM; Seo JJ; Park KM; Lee YJ; Lee SG
Transplant Proc; 2012 Mar; 44(2):523-5. PubMed ID: 22410061
[TBL] [Abstract][Full Text] [Related]
13. Pretransplantation α-fetoprotein slope and milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation.
Dumitra TC; Dumitra S; Metrakos PP; Barkun JS; Chaudhury P; Deschênes M; Paraskevas S; Hassanain M; Tchervenkov JI
Transplantation; 2013 Jan; 95(1):228-33. PubMed ID: 23222895
[TBL] [Abstract][Full Text] [Related]
14. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
[TBL] [Abstract][Full Text] [Related]
15. [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma].
Wu X; Lin Z; Fan J; Lu J; Wang L; Tang Z
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):189-91. PubMed ID: 12113675
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
17. Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hepatocellular carcinoma.
Cristani A; Cioni G; De Santis M; Chianese L; Gozzetti G; Ventura E
Hepatogastroenterology; 1994 Apr; 41(2):137-9. PubMed ID: 7520014
[TBL] [Abstract][Full Text] [Related]
18. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
19. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report.
Fujiwara Y; Takenaka K; Kajiyama K; Maeda T; Gion T; Shirabe K; Shimada M; Sugimachi K
Hepatogastroenterology; 1997; 44(15):820-3. PubMed ID: 9222698
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
